Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;58(4):255-68.
doi: 10.4103/0019-5154.113930.

Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations

Vishalakshi Viswanath  1 , Meghana M Phiske, Vinay V Gopalani
Affiliations

Systemic sclerosis: current concepts in pathogenesis and therapeutic aspects of dermatological manifestations

Vishalakshi Viswanath et al. Indian J Dermatol. 2013 Jul.

Abstract

Systemic sclerosis (SSc) is a chronic, multisystem connective tissue disease with protean clinical manifestations. Recent advances in understanding the pathogenic mechanisms have led to development of target-oriented and vasomodulatory drugs which play a pivotal role in treating various dermatological manifestations. An exhaustive literature search was done using Medline, Embase, and Cochrane library to review the recent concepts regarding pathogenesis and evidence-based treatment of salient dermatological manifestations. The concept of shared genetic risk factors for the development of autoimmune diseases is seen in SSc. It is divided into fibroproliferative and inflammatory groups based on genome-wide molecular profiling. Genetic, infectious, and environmental factors play a key role; vascular injury, fibrosis, and immune activation are the chief pathogenic factors. Vitamin D deficiency has been documented in SSc and correlates with the severity of skin involvement. Skin sclerosis, Raynaud's phenomenon (RP) with digital vasculopathies, pigmentation, calcinosis, and leg ulcers affect the patient's quality of life. Immunosuppressives, biologicals, and hematopoietic stem cell transplantation are efficacious in skin sclerosis. Endothelin A receptor antagonists, calcium-channel blockers, angiotensin receptor inhibitors, prostacyclin analogs, and phosphodiesterase type 5 (PDE-5) inhibitors are the mainstay in RP and digital vasculopathies. Pigmentation in SSc has been attributed to melanogenic potential of endothelin-1 (ET-1); the role of ET 1 antagonists and vitamin D analogs needs to be investigated. Sexual dysfunction in both male and female patients has been attributed to vasculopathy and fibrosis, wherein PDE-5 inhibitors are found to be useful. The future concepts of treating SSc may be based on the gene expression signature.

Keywords: Endothelin receptor antagonists; PDE-5 inhibitors; fibrosis; immune activation; immunosuppressives; systemic sclerosis; vascular injury.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: Nil.

Figures

Figure 1
Figure 1
Summary of etiological factors and pathogenesis of systemic sclerosis
See this image and copyright information in PMC

References

    1. Allanore Y, Dieude P, Boileau C. Genetic background of systemic sclerosis: Autoimmune genes take centre stage. Rheumatology. 2010;49:203–10. - PubMed
    1. Frech T, Khanna D, Markewitz B, Mineau G, Pimentel R, Sawitzke A. Heritability of vasculopathy, autoimmune disease, and fibrosis: A population-based study of systemic sclerosis. Arthritis Rheum. 2010;62:2109–16. - PMC - PubMed
    1. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, et al. Molecular subsets in the gene expression signatures of scleroderma skin. PLos One. 2008;3:e2696. - PMC - PubMed
    1. Balbir-Gurman A, Braun-Moscovici Y. Scleroderma-New aspects in pathogenesis and treatment, best practice and research. Clin Rheumatol. 2012;26:13–24. - PubMed
    1. Goodfield MJ, Jones SK, Veale DJ. The ‘Connective Tissue Diseases’. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 8th ed. UK: Wiley Blackwell; 2010. pp. 51.87–109.